BRCA1 and breast cancer: Nowadays, the seek for bilateral prophylactic mastectomy particularly in women with a genetic predisposition for breast cancer (e.g. BRCA-1, BRCA-2, p53) increases and accordingly represents an ideal indication for IBR of any type, knowing that neither adjuvant chemotherapy nor adjuvant radiotherapy will be required (19).